222 related articles for article (PubMed ID: 30473524)
1. Evaluation of fast disintegrating tablets of paracetamol prepared from a blend of croscarmellose sodium and Pleurotus tuber-regium powder.
Eraga SO; Arhewoh MI; Akpan FE; Iwuagwu MA
Pak J Pharm Sci; 2018 Nov; 31(6):2503-2508. PubMed ID: 30473524
[TBL] [Abstract][Full Text] [Related]
2. HIGH SHEAR GRANULATION PROCESS: ASSESSING IMPACT OF FORMULATION VARIABLES ON GRANULES AND TABLETS CHARACTERISTICS OF HIGH DRUG LOADING FORMULATION USING DESIGN OF EXPERIMENT METHODOLOGY.
Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Ali BE
Acta Pol Pharm; 2017 Mar; 74(2):551-564. PubMed ID: 29624260
[TBL] [Abstract][Full Text] [Related]
3. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
Meka VS; Yee P; Sheshala R
Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
[TBL] [Abstract][Full Text] [Related]
4. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical Characterization and Evaluation of the Binding Effect of
Desta KH; Tadese E; Molla F
Biomed Res Int; 2021; 2021():5571507. PubMed ID: 34692833
[TBL] [Abstract][Full Text] [Related]
6. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
7. Effect of humidity on the disintegrant property of alpha-cellulose.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2005; 62(1):39-44. PubMed ID: 16022492
[TBL] [Abstract][Full Text] [Related]
8. Torsemide Fast Dissolving Tablets: Development, Optimization Using Box-Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment.
El-Shenawy AA; Ahmed MM; Mansour HF; Abd El Rasoul S
AAPS PharmSciTech; 2017 Aug; 18(6):2168-2179. PubMed ID: 28050711
[TBL] [Abstract][Full Text] [Related]
9. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
Nakamura S; Fukai T; Sakamoto T
AAPS PharmSciTech; 2021 Dec; 23(1):37. PubMed ID: 34950985
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of mouth disintegrating tablets of atenolol and atorvastatin.
Sarfraz RM; Khan HU; Mahmood A; Ahmad M; Maheen S; Sher M
Indian J Pharm Sci; 2015; 77(1):83-90. PubMed ID: 25767322
[TBL] [Abstract][Full Text] [Related]
12. Preparation of medicinal carbon tablets by modified wet compression method.
Miyachi M; Onishi H; Yumoto T; Machida Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1333-8. PubMed ID: 19832633
[TBL] [Abstract][Full Text] [Related]
13. Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent.
Late SG; Banga AK
AAPS PharmSciTech; 2010 Dec; 11(4):1627-35. PubMed ID: 21086083
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies of binding potential of Prunus armeniaca and Prunus domestica gums in tablets formulations.
Rahim H; Khan MA; Sadiq A; Khan S; Chishti KA; Rahman IU
Pak J Pharm Sci; 2015 May; 28(3):909-14. PubMed ID: 26004724
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
[TBL] [Abstract][Full Text] [Related]
16. Utility of Microcrystalline Cellulose for Improving Drug Content Uniformity in Tablet Manufacturing Using Direct Powder Compression.
Nakamura S; Tanaka C; Yuasa H; Sakamoto T
AAPS PharmSciTech; 2019 Mar; 20(4):151. PubMed ID: 30903317
[TBL] [Abstract][Full Text] [Related]
17. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets.
Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI
Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749
[TBL] [Abstract][Full Text] [Related]
18. 3D extrusion printing of high drug loading immediate release paracetamol tablets.
Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082
[TBL] [Abstract][Full Text] [Related]
19. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
Mostafa HF; Ibrahim MA; Sakr A
Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
